Evidence map›Paper›PMID 34485806›Full record

ArticleJCO precision oncology2021

Report of Canonical

Ying Pang, Guangyang Yu, Madison Butler, Sivasish Sindiri, Young K Song, Jun S Wei, Xinyu Wen, Hisen-Chao Chou, Martha Quezado, Svetlana Pack and 19 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JCO precision oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Case Report: Management of aFrontiers in medicine · 2025
    Article
  4. Anticancer drugs: How to select small molecule combinations?Trends in pharmacological sciences · 2024
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Ying PangNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Guangyang YuNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Madison ButlerNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Sivasish SindiriGenetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Young K SongGenetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Jun S WeiGenetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Xinyu WenGenetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Hisen-Chao ChouGenetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Martha QuezadoLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Svetlana PackLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Liqiang XiLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Zied AbdullaevLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Olga KimNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Alice RanjanNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Mythili MerchantNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Ramya AntonyNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Lisa BorisNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Orwa AboudNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
David KamsonNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Rosandra KaplanPediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Megan MackeyRadiation Oncology Branch, National Cancer Institute, Bethesda, MD.
Kevin CamphausenRadiation Oncology Branch, National Cancer Institute, Bethesda, MD.
Kareem ZaghloulSurgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD.
Terri S ArmstrongNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Mark R GilbertNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Kenneth AldapeLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Matthias HoldhoffDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD.
Javed KhanGenetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Jing WuNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

Funding

UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development ProgramK12CA138464 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BIRKELAND, ANDREW CHARLES, LARA, PRIMO N. · 2011 to 2025
$11.4M
NCI NIH HHS K12 CA138464
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FemaleFusion Proteins, bcr-ablGlioblastomaHumansImatinib MesylateMagnetic Resonance ImagingMiddle AgedProtein Kinase InhibitorsBCR-ABL1 fusion protein, humanFusion Proteins, bcr-ablImatinib MesylateProtein Kinase Inhibitors

Identifiers

PMID34485806
PMCPMC8407655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.